Recombinant multi-species SCD1/SCD protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SCD1/SCD protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes an enzyme involved in fatty acid biosynthesis, primarily the synthesis of oleic acid. The protein belongs to the fatty acid desaturase family and is an integral membrane protein located in the endoplasmic reticulum. Transcripts of approximately 3.9 and 5.2 kb, differing only by alternative polyadenlyation signals, have been detected. A gene encoding a similar enzyme is located on chromosome 4 and a pseudogene of this gene is located on chromosome 17. [provided by RefSeq, Sep 2015]
The Alternative Names of target: Acyl-CoA desaturase,Delta(9)-desaturase (Delta-9 desaturase),FADS5,Fatty acid desaturase,MSTP008,SCD,SCD1,SCDOS,Stearoyl-CoA desaturase,hSCD1
Go
to SCD1/SCD products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP0008-Ag-1/ GM-Tg-hg-IP0008-Ag-2 | Human SCD1/SCD protein | Human |
| GM-Tg-rg-IP0008-Ag-1/ GM-Tg-rg-IP0008-Ag-2 | Rat SCD1/SCD protein | Rat |
| GM-Tg-mg-IP0008-Ag-1/ GM-Tg-mg-IP0008-Ag-2 | Mouse SCD1/SCD protein | Mouse |
| GM-Tg-cynog-IP0008-Ag-1/ GM-Tg-cynog-IP0008-Ag-2 | Cynomolgus/Rhesus macaque SCD1/SCD protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP0008-Ag-1/ GM-Tg-felg-IP0008-Ag-2 | Feline SCD1/SCD protein | Feline |
| GM-Tg-cang-IP0008-Ag-1/ GM-Tg-cang-IP0008-Ag-2 | Canine SCD1/SCD protein | Canine |
| GM-Tg-bovg-IP0008-Ag-1/ GM-Tg-bovg-IP0008-Ag-2 | Bovine SCD1/SCD protein | Bovine |
| GM-Tg-equg-IP0008-Ag-1/ GM-Tg-equg-IP0008-Ag-2 | Equine SCD1/SCD protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP0008-Ag-1/ GM-Tg-hg-IP0008-Ag-2;
GM-Tg-rg-IP0008-Ag-1/ GM-Tg-rg-IP0008-Ag-2;
GM-Tg-mg-IP0008-Ag-1/ GM-Tg-mg-IP0008-Ag-2; GM-Tg-cynog-IP0008-Ag-1/ GM-Tg-cynog-IP0008-Ag-2; GM-Tg-felg-IP0008-Ag-1/ GM-Tg-felg-IP0008-Ag-2; GM-Tg-cang-IP0008-Ag-1/ GM-Tg-cang-IP0008-Ag-2; GM-Tg-bovg-IP0008-Ag-1/ GM-Tg-bovg-IP0008-Ag-2; GM-Tg-equg-IP0008-Ag-1/ GM-Tg-equg-IP0008-Ag-2 |
| Products Name | SCD1/SCD protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | SCD1/SCD |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SCD1/SCD protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.